Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80 to 85% of all cases of lung cancer. There are different stages of NSCLC, ranging from 0 to 4; ...

Small extracellular vesicles (sEVs) are nanoscale membranous particles that have emerged as targets for liquid biopsy and as promising drug delivery vehicles. They can serve as biomarkers for ...

This review will focus on recent advances in our understanding of how these cells contribute to the tumor response to hypoxia in non-small-cell lung cancer. Lung cancer is the commonest cancer ...

Tumor cells circulating in the blood are the germ cells of breast cancer metastases. They are very rare and have not been propagated in the culture dish until now, which made research into therapy ...

High CDC20 expression promotes aneuploid cancer cell sensitivity to spindle assembly checkpoint (SAC) inhibition by ...

Although no data for T-cells were obtained from the last measurements, it turns out that since the surface is occupied at 80% by cancer cells and fibroblasts, and that the rest of the TME occupies ...

Lung cancer is one of the most common cancers. Stage 1 lung cancer is defined by tumors that are very small and have not spread (metastasized) to other parts of the body. Despite its name, it is ...

Commissions do not affect our editors' opinions or evaluations. Allianz and Clear Blue are the best small business insurance companies, according to our analysis of 28 insurers. The average cost ...

Cell C recently unveiled a refreshed brand identity at an event in Johannesburg Communications regulator Icasa has approved the transfer of Cell C’s spectrum and network licences to Blue Label ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study In this pilot study, we assessed the adoptive T-cell ...

JSE-listed Blue Label ... one of Cell C’s oldest shareholders. CellSAf, which has a 25% shareholding in Cell C, reportedly said it had not been consulted over the issue. News Round Up ...